CILGAVIMAB\TIXAGEVIMAB: 2,168 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
2,168
Total FAERS Reports
359 (16.6%)
Deaths Reported
998
Hospitalizations
2,168
As Primary/Secondary Suspect
108
Life-Threatening
23
Disabilities
First Report: 19640330 · Latest Report: 20240813
What Are the Most Common CILGAVIMAB\TIXAGEVIMAB Side Effects?
#1 Most Reported
Covid-19
521 reports (24.0%)
#2 Most Reported
Drug ineffective
123 reports (5.7%)
#3 Most Reported
Product use issue
94 reports (4.3%)
All CILGAVIMAB\TIXAGEVIMAB Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Covid-19 | 521 | 24.0% | 103 | 365 |
| Drug ineffective | 123 | 5.7% | 16 | 75 |
| Product use issue | 94 | 4.3% | 26 | 42 |
| Fatigue | 86 | 4.0% | 2 | 16 |
| Headache | 86 | 4.0% | 4 | 16 |
| Dyspnoea | 84 | 3.9% | 9 | 36 |
| Pyrexia | 81 | 3.7% | 4 | 48 |
| Nausea | 68 | 3.1% | 0 | 17 |
| Dizziness | 64 | 3.0% | 1 | 18 |
| Breakthrough covid-19 | 51 | 2.4% | 6 | 34 |
| Pneumonia | 49 | 2.3% | 8 | 34 |
| Atrial fibrillation | 48 | 2.2% | 3 | 31 |
| Death | 48 | 2.2% | 48 | 3 |
| Cough | 47 | 2.2% | 2 | 13 |
| Pruritus | 46 | 2.1% | 0 | 6 |
| Asthenia | 45 | 2.1% | 2 | 16 |
| Chills | 43 | 2.0% | 0 | 11 |
| Rash | 43 | 2.0% | 0 | 10 |
| Covid-19 pneumonia | 42 | 1.9% | 19 | 30 |
| Chest pain | 40 | 1.9% | 4 | 11 |
Who Reports CILGAVIMAB\TIXAGEVIMAB Side Effects? Age & Gender Data
Gender: 47.6% female, 52.4% male. Average age: 62.2 years. Most reports from: US. View detailed demographics →
Is CILGAVIMAB\TIXAGEVIMAB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2006 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 0 |
| 2017 | 1 | 1 | 0 |
| 2019 | 1 | 0 | 1 |
| 2020 | 2 | 0 | 0 |
| 2021 | 18 | 1 | 7 |
| 2022 | 1,233 | 206 | 522 |
| 2023 | 323 | 30 | 263 |
| 2024 | 19 | 6 | 13 |
What Is CILGAVIMAB\TIXAGEVIMAB Used For?
| Indication | Reports |
|---|---|
| Covid-19 prophylaxis | 1,105 |
| Covid-19 | 287 |
| Covid-19 treatment | 146 |
| Immunodeficiency | 76 |
| Prophylaxis | 57 |
| Product used for unknown indication | 30 |
| Immunisation | 23 |
| Immunosuppression | 15 |
| Renal transplant | 14 |
| Covid-19 immunisation | 12 |
CILGAVIMAB\TIXAGEVIMAB vs Alternatives: Which Is Safer?
CILGAVIMAB\TIXAGEVIMAB vs CILOSTAZOL
CILGAVIMAB\TIXAGEVIMAB vs CILTACABTAGENE AUTOLEUCEL
CILGAVIMAB\TIXAGEVIMAB vs CIMETIDINE
CILGAVIMAB\TIXAGEVIMAB vs CIMZIA
CILGAVIMAB\TIXAGEVIMAB vs CINACALCET
CILGAVIMAB\TIXAGEVIMAB vs CINNARIZINE
CILGAVIMAB\TIXAGEVIMAB vs CINRYZE
CILGAVIMAB\TIXAGEVIMAB vs CIPRO
CILGAVIMAB\TIXAGEVIMAB vs CIPROFLOXACIN
CILGAVIMAB\TIXAGEVIMAB vs CIPROFLOXACIN\DEXAMETHASONE
Official FDA Label for CILGAVIMAB\TIXAGEVIMAB
Official prescribing information from the FDA-approved drug label.